Financial Strategies Acquisition Corp. Announces Merger with Austin Biosciences Corp, A Texas Biotechnology Platform Company

DALLAS and AUSTIN, Texas, Feb. 13, 2023 /PRNewswire/ — Financial Strategies Acquisition Corp. (Nasdaq: FXCO) (“FXCO”)(the “Company”)., a Special Purpose Acquisition Company led by CEO Alexander V. Schinzing, today announced the execution of a definitive business combination agreement with Austin Biosciences Corp. (“Austin Biosciences”).